Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s stock price was down 3.8% during trading on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares traded hands during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Down 3.8%
The stock has a market cap of C$52.28 million and a price-to-earnings ratio of -0.37. The company has a debt-to-equity ratio of 35.45, a quick ratio of 2.61 and a current ratio of 2.97. The firm’s 50-day simple moving average is C$0.26 and its two-hundred day simple moving average is C$0.26.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.
Further Reading
- Five stocks we like better than Emerald Health Therapeutics
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
